|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 48/00 | |
| C07H 21/02 | |||
| C07H 21/04 |
| (11) | Patento numeris | 2763701 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12838676.0 |
| Europos patento paraiškos padavimo data | 2012-10-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-08-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-12-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/058519 |
| Data | 2012-10-03 |
| (87) | Numeris | WO 2013/052523 |
| Data | 2013-04-11 |
| (30) | Numeris | Data | Šalis |
| 201161542533 P | 2011-10-03 | US |
| (72) |
DE FOUGEROLLES, Antonin, US
ROY, Atanu, US
SCHRUM, Jason P., US
SIDDIQI, Suhaib, US
HATALA, Paul, US
BANCEL, Stephane, US
|
| (73) |
Moderna Therapeutics, Inc.,
320 Bent Street, Cambridge, Massachusetts 02141,
US
|
| (54) | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF |
| MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF |